LIM-domain-only proteins in cancer

Nature Reviews Cancer

Volumn 13, Issue 2, 2013, Pages 111-122

  Matthews, Jacqueline M ^a   Lester, Krystal ^a   Joseph, Soumya ^a   Curtis, David J ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AUTOANTIGEN; GENE THERAPY AGENT; LIM DOMAIN ONLY PROTEIN 1; LIM DOMAIN ONLY PROTEIN 2; LIM DOMAIN ONLY PROTEIN 3; LIM DOMAIN ONLY PROTEIN 4; LIM DOMAIN ONLY PROTEIN 4 INHIBITOR; LIM PROTEIN; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; B CELL LEUKEMIA; BREAST CANCER; CANCER GENE THERAPY; CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CELL CYCLE REGULATION; CELL RENEWAL; CHROMOSOME TRANSLOCATION; COMPLEX FORMATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; LARGE CELL LYMPHOMA; METASTASIS; NEOPLASM; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SOLID TUMOR; T CELL LEUKEMIA; TRANSCRIPTION REGULATION; X LINKED SEVERE COMBINED IMMUNODEFICIENCY;

ANIMALS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIM DOMAIN PROTEINS; NEOPLASMS; PROTEIN INTERACTION DOMAINS AND MOTIFS;

EID: 84873058654     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3418     Document Type: Review

References (131)

1. Bach, I. The LIM domain: Regulation by association. Mech. Dev. 91, 5-17 (2000
2. Matthews, J. M. et al.It takes two to tango: The structure and function of LIM, RING, PHD and MYND domains. Curr. Pharm. Des. 15, 3681-3696 (2009
3. Boehm, T. et al.The mechanism of chromosomal translocation t(11-14) involving the T-cell receptor C-δ locus on human-chromosome 14q11 and a transcribed region of chromosome 11p15. EMBO J. 7, 385-394 (1988
4. Boehm, T., Foroni, L., Kennedy, M. & Rabbitts, T.H. The rhombotin gene belongs to a class of transcriptional regulators with a potential novel protein dimerisation motif. Oncogene 5, 1103-1105 (1990
5. McGuire, E.A. et al.The T(11-14)(p15-q11) in a T-cell acute lymphoblastic-leukemia cell-line activates multiple transcripts, including TTG-1, a gene encoding a potential zinc finger protein Mol. Cell. Biol. 9, 2124-2132 (1989
6. Boehm, T., Foroni, L., Kaneko, Y., Perutz, M.F. & Rabbitts, T.H. The rhombotin family of cysteine-rich LIM-domain oncogenes: Distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc. Natl Acad. Sci. USA 88, 4367-4371 (1991
7. Royer-Pokora, B., Loos, U. & Ludwig, W.D. TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene 6, 1887-1893 (1991
8. Van Vlierberghe, P. et al.The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood 108, 3520-3529 (2006
9. Hammond, S.M., Crable, S.C. & Anderson, K.P. Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemia. Leuk. Res. 29, 89-97 (2005
10. Ferrando, A.A. et al.Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1, 75-87 (2002
11. Oram, S.H. et al.A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients. Oncogene 29, 5796-5808 (2010
12. Wilson, N.K. et al.Combinatorial transcriptional control in blood stem/progenitor cells: Genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 7, 532-544 (2010
13. Warren, A.J. et al.The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 78, 45-57 (1994
14. Visvader, J.E., Mao, X., Fujiwara, Y., Hahm, K. & Orkin, S.H. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation. Proc. Natl Acad. Sci. USA 94, 13707-13712 (1997
15. Yamada, Y. et al.The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc. Natl Acad. Sci. USA 95, 3890-3895 (1998
16. Yamada, Y., Pannell, R., Forster, A. & Rabbitts, T.H. The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. Proc. Natl Acad. Sci. USA 97, 320-324 (2000
17. Herblot, S., Steff, A.M., Hugo, P., Aplan, P.D. & Hoang, T. SCL and LMO1 alter thymocyte differentiation: Inhibition of E2A-HEB function and pre-T α chain expression. Nature Immunol. 1, 138-144 (2000
18. Neale, G. A., Rehg, J. E. & Goorha, R. M. Disruption of T-cell differentiation precedes T-cell tumor formation in LMO-2 (rhombotin-2) transgenic mice. Leukemia 11 (Suppl. 3), 289-290 (1997
19. Larson, R. C. et al.T cell tumours of disparate phenotype in mice transgenic for Rbtn-2. Oncogene 9, 3675-3681 (1994
20. McCormack, M. P. et al.The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal. Science 327, 879-883 (2010
21. Tremblay, M. et al.Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. Genes Dev. 24, 1093-1105 (2010
22. Martins, V. C. et al.Thymus-autonomous T cell development in the absence of progenitor import. J. Exp. Med. 209, 1409-1417 (2012
23. Peaudecerf, L. et al.Thymocytes may persist and differentiate without any input from bone marrow progenitors. J. Exp. Med. 209, 1401-1408 (2012
24. O'Neil, J. et al.Activating Notch1 mutations in mouse models of T-ALL. Blood 107, 781-785 (2006
25. Treanor, L. M. et al.Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies. Blood 117, 5453-5462 (2011
26. Homminga, I., Pieters, R. & Meijerink, J. P. NKL homeobox genes in leukemia. Leukemia 26, 572-581 (2012
27. Homminga, I. et al.Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell 19, 484-497 (2011
28. George, A., Morse Iii, H. C. & Justice, M. J. The homeobox gene Hex induces T-cell-derived lymphomas when overexpressed in hematopoietic precursor cells. Oncogene 22, 6764-6773 (2003
29. Kusy, S. et al.NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia. J. Exp. Med. 207, 2141-2156 (2010
30. Nagel, S. et al.Transcriptional activation of prostate specific homeobox gene NKX3-1 in subsets of T-cell lymphoblastic leukemia (T-ALL). PLoS ONE 7, e40747 (2012
31. Wadman, I. A. et al.The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J. 16, 3145-3157 (1997
32. Grutz, G. G. et al.The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells. EMBO J. 17, 4594-4605 (1998
33. Palii, C. G. et al.Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages. EMBO J. 30, 494-509 (2011
34. Sanda, T. et al.Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. Cancer Cell 22, 209-221 (2012
35. Tripic, T. et al.SCL and associated proteins distinguish active from repressive GATA transcription factor complexes. Blood 113, 2191-2201 (2009
36. Soler, E. et al.The genome-wide dynamics of the binding of Ldb1 complexes during erythroid differentiation. Genes Dev. 24, 277-289 (2010
37. Ryan, D. P. et al.Identification of the key LMO2-binding determinants on Ldb1. J. Mol. Biol. 359, 66-75 (2006
38. Matthews, J. M. & Visvader, J. E. LIM-domain-binding protein 1: A multifunctional cofactor that interacts with diverse proteins. EMBO Rep. 4, 1132-1137 (2003
39. Song, S. H., Hou, C. & Dean, A. A positive role for NLI/ Ldb1 in long-range β-globin locus control region function. Mol. Cell 28, 810-822 (2007
40. Morcillo, P., Rosen, C., Baylies, M. K. & Dorsett, D. Chip, a widely expressed chromosomal protein required for segmentation and activity of a remote wing margin enhancer in Drosophila. Genes Dev. 11, 2729-2740 (1997
41. Jurata, L. W. & Gill, G. N. Functional analysis of the nuclear LIM domain interactor NLI. Mol. Cell. Biol. 17, 5688-5698 (1997
42. Jurata, L. W., Pfaff, S. L. & Gill, G. N. The nuclear LIM domain interactor NLI mediates homo- and heterodimerization of LIM domain transcription factors. J. Biol. Chem. 273, 3152-3157 (1998
43. Cross, A. J., Jeffries, C. M., Trewhella, J. & Matthews, J. M. L. I. M. Domain binding proteins 1 and 2 have different oligomeric states. J. Mol. Biol. 399, 133-144 (2010
44. Wilkinson-White, L. et al.Structural basis of simultaneous recruitment of the transcriptional regulators LMO2 and FOG1/ZFPM1 by the transcription factor GATA1. Proc. Natl Acad. Sci. USA 108, 14443-14448 (2011
45. El Omari, K. et al.Structure of the leukemia oncogene LMO2: Implications for the assembly of a hematopoietic transcription factor complex. Blood 117, 2146-2156 (2011
46. Kumar, Madhu, S. et al.The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer. Cell 149, 642-655 (2012
47. Souroullas, G. P., Salmon, J. M., Sablitzky, F., Curtis, D. J. & Goodell, M. A. Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival. Cell Stem Cell 4, 180-186 (2009
48. Li, L. et al.Nuclear adaptor Ldb1 regulates a transcriptional program essential for the maintenance of hematopoietic stem cells. Nature Immunol. 12, 129-136 (2011
49. Rodrigues, N. P., Tipping, A. J., Wang, Z. & Enver, T. GATA-2 mediated regulation of normal hematopoietic stem/progenitor cell function, myelodysplasia and myeloid leukemia. Int. J. Biochem. 44, 457-460 (2012
50. Ku, C.-J., Hosoya, T., Maillard, I. & Engel, J. D. GATA-3 regulates hematopoietic stem cell maintenance and cell-cycle entry. Blood 119, 2242-2251 (2012
51. Bain, G. et al.E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17, 4782-4791 (1997
52. Kelliher, M. A., Seldin, D. C. & Leder, P. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIα. EMBO J. 15, 5160-5166 (1996
53. Larson, R. C. et al.Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J. 15, 1021-1027 (1996
54. Beltran, A. C., Dawson, P. E. & Gottesfeld, J. M. Role of DNA sequence in the binding specificity of synthetic basic-helix-loop-helix domains. Chembiochem 6, 104-113 (2005
55. Ryan, D. P., Duncan, J. L., Lee, C., Kuchel, P. W. & Matthews, J. M. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12. Proteins 70, 1461-1474 (2008
56. Draheim, K. M. et al.A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice. Oncogene 30, 1252-1260 (2011
57. O'Neil, J., Billa, M., Oikemus, S. & Kelliher, M. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice. Oncogene 20, 3897-3905 (2001
58. Lossos, I. S. et al.Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N. Engl. J. Med. 350, 1828-1837 (2004
59. Natkunam, Y. et al.The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood 109, 1636-1642 (2007
60. Malumbres, R. et al.LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome. Haematologica 96, 980-986 (2011
61. Cubedo, E. et al.Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma. Blood 119, 5478-5491 (2012
62. Inaba, T. et al.Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 257, 531-534 (1992
63. Hunger, S. P., Ohyashiki, K., Toyama, K. & Cleary, M. L. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev. 6, 1608-1620 (1992
64. De Boer, J. et al.The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors. Leukemia 25, 321-330 (2011
65. Armeanu-Ebinger, S. et al.Differential expression of invasion promoting genes in childhood rhabdomyosarcoma. Int. J. Oncol. 38, 993-1000 (2011
66. Mizunuma, H., Miyazawa, J., Sanada, K. & Imai, K. The LIM-only protein, LMO4, and the LIM domain-binding protein, LDB1, expression in squamous cell carcinomas of the oral cavity. Br. J. Cancer 88, 1543-1548 (2003
67. Kwong, R. A. et al.LMO4 expression in squamous cell carcinoma of the anterior tongue. Histopathology 58, 477-480 (2011
68. Murphy, N. C. et al.Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma. Br. J. Cancer 98, 537-541 (2008
69. Nakata, K. et al.LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer. Neoplasia 11, 712-719 (2009
70. Hahm, K. et al.Defective neural tube closure and anteroposterior patterning in mice lacking the LIM protein LMO4 or its interacting partner Deaf-1. Mol. Cell. Biol. 24, 2074-2082 (2004
71. Tse, E. et al.Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice. Mol. Cell. Biol. 24, 2063-2073 (2004
72. Racevskis, J., Dill, A., Sparano, J. A. & Ruan, H. Molecular cloning of LMO41, a new human LIM domain gene. Biochim. Biophys. Acta 1445, 148-153 (1999
73. Visvader, J. E. et al.The LIM domain gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and is overexpressed in breast cancer. Proc. Natl Acad. Sci. USA 98, 14452-14457 (2001
74. Sum, E. Y. et al.Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer. Proc. Natl Acad. Sci. USA 102, 7659-7664 (2005
75. Montaez-Wiscovich, M. E. et al.Aberrant expression of LMO4 induces centrosome amplification and mitotic spindle abnormalities in breast cancer cells. J. Pathol. 222, 271-281 (2010
76. Wang, N. et al.The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells. Oncogene 26, 6431-6441 (2007
77. Wang, N. et al.Expression of an engrailed-LMO4 fusion protein in mammary epithelial cells inhibits mammary gland development in mice. Oncogene 23, 1507-1513 (2004
78. Wittlin, S., Sum, E. Y., Jonas, N. K., Lindeman, G. J. & Visvader, J. E. Two promoters within the human LMO4 gene contribute to its overexpression in breast cancer cells. Genomics 82, 280-287 (2003
79. Montanez-Wiscovich, M. E. et al.LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression. Oncogene 28, 3608-3618 (2009
80. Sum, E. Y. et al.The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity. J. Biol. Chem. 277, 7849-7856 (2002
81. Liew, C. W., Kwan, A. H., Stokes, P. H., Mackay, J. P. & Matthews, J. M. 1H, 15N and 13C assignments of an intramolecular LMO4-LIM1/CtIP complex. Biomol. NMR Assign. 6, 31-34 (2012
82. Chen, P. L. et al.Inactivation of CtIP leads to early embryonic lethality mediated by G1 restraint and to tumorigenesis by haploid insufficiency. Mol. Cell. Biol. 25, 3535-3542 (2005
83. Singh, R. R., Barnes, C. J., Talukder, A. H., Fuqua, S. A. & Kumar, R. Negative regulation of estrogen receptor α transactivation functions by LIM domain only 4 protein. Cancer Res. 65, 10594-10601 (2005
84. Setogawa, T., Shinozaki-Yabana, S., Masuda, T., Matsuura, K. & Akiyama, T. The tumor suppressor LKB1 induces p21 expression in collaboration with LMO4, GATA-6, and Ldb1. Biochem. Biophys. Res. Commun. 343, 1186-1190 (2006
85. Cubeddu, L., Joseph, S., Richard, D. J. & Matthews, J. M. Contribution of DEAF1 structural domains to the interaction with the breast cancer oncogene LMO4. PLoS ONE 7, e39218 (2012
86. Kenny, D. A., Jurata, L. W., Saga, Y. & Gill, G. N. Identification and characterization of LMO4, an LMO gene with a novel pattern of expression during embryogenesis. Proc. Natl Acad. Sci. USA 95, 11257-11262 (1998
87. Grutz, G., Forster, A. & Rabbitts, T. H. Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: A candidate for displacement by LMO proteins in T cell acute leukaemia. Oncogene 17, 2799-2803 (1998
88. Deane, J. E. et al.Tandem LIM domains provide synergistic binding in the LMO4:Ldb1 complex. EMBO J. 23, 3589-3598 (2004
89. Deane, J. E. et al.Structural basis for the recognition of ldb1 by the N-terminal LIM domains of LMO2 and LMO4. EMBO J. 22, 2224-2233 (2003
90. Jeffries, C. et al.Stabilization of a binary protein complex through intein-mediated circularization. Protein Sci. 15, 2612-2618 (2006
91. Manetopoulos, C., Hansson, A., Karlsson, J., Jonsson, J. I. & Axelson, H. The LIM-only protein LMO4 modulates the transcriptional activity of HEN1. Biochem. Biophys. Res. Commun. 307, 891-899 (2003
92. Asprer, J. S. T. et al.LMO4 functions as a co-activator of neurogenin 2 in the developing cortex. Development 138, 2823-2832 (2011
93. Lu, Z. et al.LMO4 can interact with Smad proteins and modulate transforming growth factor-β signaling in epithelial cells. Oncogene 25, 2920-2930 (2006
94. Ma, S. et al.The significance of LMO2 expression in the progression of prostate cancer. J. Pathol. 211, 278-285 (2007
95. Umbas, R. et al.Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 52, 5104-5109 (1992
96. Ahmad, I., Sansom, O. J. & Leung, H. Y. Advances in mouse models of prostate cancer. Expert Rev. Mol. Med. 10, e16 (2008
97. Hinks, G. L. et al.Expression of LIM protein genes Lmo1, Lmo2, and Lmo3 in adult mouse hippocampus and other forebrain regions: Differential regulation by seizure activity. J. Neurosci. 17, 5549-5559 (1997
98. Susa, T. et al.The highly related LIM factors, LMO1, LMO3 and LMO4, play different roles in the regulation of the pituitary glycoprotein hormone α-subunit (αGSU) gene. Biosci. Rep. 30, 51-58 (2009
99. Hislop, N. R. et al.Grhl3 and Lmo4 play coordinate roles in epidermal migration. Dev. Biol. 321, 263-272 (2008
100. Lumsden, A. Neural development. A 'LIM code' for motor neurons? Curr. Biol. 5, 491-495 (1995
101. Aoyama, M. et al.LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma. Cancer Res. 65, 4587-4597 (2005
102. Isogai, E. et al.Oncogenic LMO3 collaborates with HEN2 to enhance neuroblastoma cell growth through transactivation of Mash1. PLoS ONE 6, e19297 (2011
103. Watt, F. et al.A novel MASH1 enhancer with N-myc and CREB-binding sites is active in neuroblastoma. Cancer Gene Ther. 14, 287-296 (2006
104. Wang, K. et al.Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature 469, 216-220 (2011
105. McCaffrey, L. M. & Macara, I. G. Epithelial organization, cell polarity and tumorigenesis. Trends Cell Biol. 21, 727-735 (2011
106. Yilmaz, M. & Christofori, G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 28, 15-33 (2009
107. Heldin, C.-H., Vanlandewijck, M. & Moustakas, A. Regulation of EMT by TGFβ in cancer. FEBS Lett. 586, 1959-1970 (2012
108. Jδrvinen, P. M. & Laiho, M. LIM-domain proteins in transforming growth factor β-induced epithelial-to-mesenchymal transition and myofibroblast differentiation. Cell. Signal. 24, 819-825 (2012
109. Kadrmas, J. L. & Beckerle, M. C. The LIM domain: From the cytoskeleton to the nucleus. Nature Rev. Mol. Cell Biol. 5, 920-931 (2004
110. Deleuze, V. et al.TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells. Mol. Cell. Biol. 27, 2687-2697 (2007
111. Nam, C. H. et al.An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions. Oncogene 27, 4962-4968 (2008
112. Appert, A. et al.Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia. Cancer Res. 69, 4784-4790 (2009
113. Yamada, Y., Pannell, R., Forster, A. & Rabbitts, T. H. The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: A new anti-angiogenesis drug target. Oncogene 21, 1309-1315 (2002
114. Visvader, J. E., Fujiwara, Y. & Orkin, S. H. Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev. 12, 473-479 (1998
115. Deleuze, V. et al.Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells. PLoS ONE 7, e40484 (2012
116. Deane, J. E. et al.Design, production and characterization of FLIN2 and FLIN4: The engineering of intramolecular ldb1:LMO complexes. Protein Eng. 14, 493-499 (2001
117. Dastmalchi, S. et al.Solution structure of a tethered Lmo2(LIM2) /Ldb1(LID) complex. Protein Sci. 21, 1768-1774 (2012
118. Cavazzana-Calvo, M. et al.Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669-672 (2000
119. Gaspar, H. B. et al.Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped γretroviral vector. Lancet 364, 2181-2187 (2004
120. Howe, S. J. et al.Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J. Clin. Invest. 118, 3143-3150 (2008
121. Hacein-Bey-Abina, S. et al.Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 118, 3132-3142 (2008
122. Clappier, E. et al.Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias. Leukemia 20, 82-86 (2005
123. Yamada, K. et al.Identification of a high incidence region for retroviral vector integration near exon 1 of the LMO2 locus. Retrovirology 6, 79 (2009
124. Bester, A. C. et al.Fragile sites are preferential targets for integrations of MLV vectors in gene therapy. Gene Ther. 13, 1057-1059 (2006
125. Dave, U. P. et al.Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy. PLoS Genet. 5, e1000491 (2009
126. Nam, C. H. & Rabbitts, T. H. The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion. Mol. Ther. 13, 15-25 (2006
127. Pike-Overzet, K. et al.Ectopic retroviral expression of LMO2, but not IL2Rγ, blocks human T-cell development from CD34+ cells: Implications for leukemogenesis in gene therapy. Leukemia 21, 754-763 (2007
128. Hacein-Bey-Abina, S. et al.LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419 (2003
129. Royer-Pokora, B. et al.The TTG-2/RBTN2 T cell oncogene encodes two alternative transcripts from two promoters: The distal promoter is removed by most 11p13 translocations in acute T cell leukaemia's (T-ALL). Oncogene 10, 1353-1360 (1995
130. Rothenberg, E. V., Moore, J. E. & Yui, M. A. Launching the T-cell-lineage developmental programme. Nature Rev. Immunol. 8, 9-21 (2008
131. Curtis, D. J. & McCormack, M. P. The molecular basis of Lmo2-induced T-cell acute lymphoblastic leukemia. Clin. Cancer Res. 16, 5618-5623 (2010